Description générale
Ifosfamide is a nitrogen mustard alkylating agent used in treatment protocols for bone and soft tissue sarcomas, and testicular and ovarian cancers.
INN
Ifosfamide
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2009
(TRS
958)
pour
Other specified malignant neoplasms of the ovary
Ajouté en 2009
(TRS
958)
pour
Ewing sarcoma of bone and articular cartilage of unspecified sites
Ajouté en 2009
(TRS
958)
pour
Rhabdomyosarcoma primary site
Ajouté en 2009
(TRS
958)
pour
Osteosarcoma of bone and articular cartilage of unspecified sites
Ajouté en 2009
(TRS
958)
pour
Germ cell tumour of testis
Ajouté en 2009
(TRS
958)
pour
Unspecified malignant neoplasms of ill-defined or unspecified sites
Retiré en 2015
(TRS
994)
pour
Unspecified malignant neoplasms of ill-defined or unspecified sites
Ajouté en 2021
(TRS
1035)
pour
Burkitt lymphoma including Burkitt leukaemia
Ajouté en 2021
(TRS
1035)
pour
Malignant neoplasms of kidney, except renal pelvis
Ajouté en 2023
(TRS
1049)
pour
Anaplastic large cell lymphoma, ALK-positive
Ajouté en 2023
(TRS
1049)
pour
Anaplastic large cell lymphoma, ALK-negative
Wikipédia
DrugBank
Recommandations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
- Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection
Indications
Osteosarcoma of bone and articular cartilage of unspecified sites
Other specified malignant neoplasms of the ovary
Germ cell tumour of testis
Rhabdomyosarcoma primary site
Ewing sarcoma of bone and articular cartilage of unspecified sites
Unspecified malignant neoplasms of ill-defined or unspecified sites
Burkitt lymphoma including Burkitt leukaemia
Malignant neoplasms of kidney, except renal pelvis
Anaplastic large cell lymphoma, ALK-positive
Anaplastic large cell lymphoma, ALK-negative